论文信息 - A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC). - 字舞流文

A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC).

B. Han | Yiping Zhang | Shucai Zhang | K. Ying | K. Ma | S. Jiao | Mei-na Wu | Chang-li Wang | Li Zhang | C. You | A. Gu | Yan Sun | Junye Wang | Xingsheng Hu | Yin-xiang Wang | F. Tan | L. Ding | Jintao He | Jiewen Peng | X. Jia